200 related articles for article (PubMed ID: 18509067)
1. Effect of pregnancy on cytochrome P450 3a and P-glycoprotein expression and activity in the mouse: mechanisms, tissue specificity, and time course.
Zhang H; Wu X; Wang H; Mikheev AM; Mao Q; Unadkat JD
Mol Pharmacol; 2008 Sep; 74(3):714-23. PubMed ID: 18509067
[TBL] [Abstract][Full Text] [Related]
2. Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir.
van Waterschoot RA; ter Heine R; Wagenaar E; van der Kruijssen CM; Rooswinkel RW; Huitema AD; Beijnen JH; Schinkel AH
Br J Pharmacol; 2010 Jul; 160(5):1224-33. PubMed ID: 20590614
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
[TBL] [Abstract][Full Text] [Related]
5. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors.
Gupta A; Mugundu GM; Desai PB; Thummel KE; Unadkat JD
Drug Metab Dispos; 2008 Jun; 36(6):1172-80. PubMed ID: 18332086
[TBL] [Abstract][Full Text] [Related]
6. Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease.
Fakhoury M; Lecordier J; Medard Y; Peuchmaur M; Jacqz-Agrain E
Inflamm Bowel Dis; 2006 Aug; 12(8):745-9. PubMed ID: 16917230
[TBL] [Abstract][Full Text] [Related]
7. Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver.
van Waterschoot RA; Rooswinkel RW; Wagenaar E; van der Kruijssen CM; van Herwaarden AE; Schinkel AH
FASEB J; 2009 Jan; 23(1):224-31. PubMed ID: 18794335
[TBL] [Abstract][Full Text] [Related]
8. How important is intestinal cytochrome P450 3A metabolism?
van Herwaarden AE; van Waterschoot RA; Schinkel AH
Trends Pharmacol Sci; 2009 May; 30(5):223-7. PubMed ID: 19328560
[TBL] [Abstract][Full Text] [Related]
9. PXR/CYP3A4-humanized mice for studying drug-drug interactions involving intestinal P-glycoprotein.
Holmstock N; Gonzalez FJ; Baes M; Annaert P; Augustijns P
Mol Pharm; 2013 Mar; 10(3):1056-62. PubMed ID: 23360470
[TBL] [Abstract][Full Text] [Related]
10. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.
Fakhoury M; Litalien C; Medard Y; Cavé H; Ezzahir N; Peuchmaur M; Jacqz-Aigrain E
Drug Metab Dispos; 2005 Nov; 33(11):1603-7. PubMed ID: 16049125
[TBL] [Abstract][Full Text] [Related]
11. [Effects of intestinal flora on the expression of cytochrome P450 3A in the liver].
Ishii M; Toda T; Ikarashi N; Ochiai W; Sugiyama K
Yakugaku Zasshi; 2012; 132(3):301-10. PubMed ID: 22382834
[TBL] [Abstract][Full Text] [Related]
12. Physiologically-Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P-glycoprotein and Cytochrome P450 3A.
Otsuka Y; Choules MP; Bonate PL; Komatsu K
CPT Pharmacometrics Syst Pharmacol; 2020 Nov; 9(11):659-669. PubMed ID: 33030266
[TBL] [Abstract][Full Text] [Related]
13. Variation in oral clearance of saquinavir is predicted by CYP3A5*1 genotype but not by enterocyte content of cytochrome P450 3A5.
Mouly SJ; Matheny C; Paine MF; Smith G; Lamba J; Lamba V; Pusek SN; Schuetz EG; Stewart PW; Watkins PB
Clin Pharmacol Ther; 2005 Dec; 78(6):605-18. PubMed ID: 16338276
[TBL] [Abstract][Full Text] [Related]
14. Expression of cytochromes P450 3A and P-glycoprotein in human large intestine in paired tumour and normal samples.
Canaparo R; Nordmark A; Finnström N; Lundgren S; Seidegård J; Jeppsson B; Edwards RJ; Boobis AR; Rane A
Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):240-8. PubMed ID: 17371528
[TBL] [Abstract][Full Text] [Related]
15. A novel female-specific member of the CYP3A gene subfamily in the mouse liver.
Sakuma T; Takai M; Endo Y; Kuroiwa M; Ohara A; Jarukamjorn K; Honma R; Nemoto N
Arch Biochem Biophys; 2000 May; 377(1):153-62. PubMed ID: 10775455
[TBL] [Abstract][Full Text] [Related]
16. A double transgenic mouse model expressing human pregnane X receptor and cytochrome P450 3A4.
Ma X; Cheung C; Krausz KW; Shah YM; Wang T; Idle JR; Gonzalez FJ
Drug Metab Dispos; 2008 Dec; 36(12):2506-12. PubMed ID: 18799805
[TBL] [Abstract][Full Text] [Related]
17. Modulation of P-glycoprotein expression by cytochrome P450 3A inducers in male and female rat livers.
Salphati L; Benet LZ
Biochem Pharmacol; 1998 Feb; 55(4):387-95. PubMed ID: 9514072
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities.
Kharasch ED; Bedynek PS; Walker A; Whittington D; Hoffer C
Clin Pharmacol Ther; 2008 Oct; 84(4):506-12. PubMed ID: 19238656
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine growth restriction may reduce hepatic drug metabolism in the early neonatal period.
Soo JY; Wiese MD; Berry MJ; McMillen IC; Morrison JL
Pharmacol Res; 2018 Aug; 134():68-78. PubMed ID: 29890254
[TBL] [Abstract][Full Text] [Related]
20. Zonation of the drug-metabolizing enzyme cytochrome P450 3A in infant mice begins in pre-weaning period.
Kitaoka S; Hatogai J; Ochiai W; Sugiyama K
J Toxicol Sci; 2018; 43(3):223-227. PubMed ID: 29540656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]